Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
Aug 22 (Reuters) - The U.S. Food and Drug Administration on Thursday approved updated COVID-19 vaccines made by Pfizer (PFE.N)
BioNTech says FDA lifts partial hold on its cancer drug trial
The FDA has allowed MediLink Therapeutics to restart a phase 1 trial of its BioNTech-partnered antibody-drug conjugate (ADC) that saw three fatalities after the companies confirmed that only lower doses will be used.
Pfizer, BioNTech’s Mixed Phase III Data Sets Back COVID-Flu Vaccine Candidate
Pfizer and BioNTech may have a strong pedigree in the mRNA vaccine game, but, when it comes to flu, they’ve run up against the same problem as their peers—neutralizing influenza strain B.
As sales from COVID-19 vaccines continue to flounder, lawsuits associated with the products keep on piling up. In the latest, the University of Pennsylvania targets Pfizer’s Cormirnaty vaccine partner BioNTech for additional royalties it allegedly owes to the university.
Announced positive data from multiple mRNA cancer vaccine clinical trials, including topline results from the ongoing Phase 2 evaluating FixVac candidate BNT111Launched updated variant-adapted...
BioNTech ends work on Genmab-partnered bispecific antibody acasunlimab
BioNTech losses quadruple in Q2 amid shift to cancer drugs